AI-generated summary
This narrative review synthesizes evidence on how light modulates pain and the mechanisms involved. The authors report that cutaneous red light at 660 nm reduced pain in neuropathies and complex regional pain syndrome-I, while visual exposure to the same wavelength was reported to exacerbate migraine and induce functional pain in animal models. Visual green light exposure was associated with pain reduction in conditions such as migraine and fibromyalgia.
- Who or what was studied
- unclear
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes a narrative review, which is not a systematic synthesis, and the number of included studies is not stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Phototherapy, Wavelength, Migraine, Fibromyalgia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.